Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Unknown 1Terminated 1Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Leukemia 31Leukemia, Promyelocytic, Acute 27Multiple Myeloma 17Leukemia, Myeloid, Acute 16Neoplasms, Plasma Cell 12Myelodysplastic Syndromes 12Leukemia, Myelomonocytic, Chronic 9Precursor Cell Lymphoblastic Leukemia-Lymphoma 8Anemia, Refractory, with Excess of Blasts 7Lymphoma 6Leukemia, Monocytic, Acute 6Leukemia, Lymphocytic, Chronic, B-Cell 6Blast Crisis 6Neoplasms 5Lymphoma, Non-Hodgkin 5Lymphoma, Follicular 5Leukemia, Myelomonocytic, Acute 5Leukemia, Megakaryoblastic, Acute 5Leukemia, Erythroblastic, Acute 5Burkitt Lymphoma 5Recurrence 4Myeloproliferative Disorders 4Myelodysplastic-Myeloproliferative Diseases 4Lymphoma, Mantle-Cell 4Lymphoma, Large-Cell, Immunoblastic 4Lymphoma, Large B-Cell, Diffuse 4Leukemia, Myeloid, Chronic-Phase 4Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 4Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4Central Nervous System Neoplasms 4

Interventions

Sorafenib 222lenvatinib 147Bevacizumab 131Nivolumab 87atezolizumab 81pembrolizumab 74Radiosurgery 71durvalumab 63sintilimab 61Oxaliplatin 60Fluorouracil 56Doxorubicin 47tislelizumab 46apatinib 45Radiofrequency Ablation 44Hepatectomy 43camrelizumab 41Leucovorin 41Radiotherapy 40tremelimumab 37Magnetic Resonance Spectroscopy 36regorafenib 34Capecitabine 30Immune Checkpoint Inhibitors 29Folfox protocol 29Cisplatin 28cabozantinib 26Gemcitabine 26Cyclophosphamide 26Ipilimumab 25

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Carcinoma, Hepatocellular × Arsenic Trioxide × Clear all
NCT00128596 2017-04-27

Arsenic Trioxide in Treating Patients With Metastatic Liver Cancer That Cannot Be Removed by Surgery

University of Pittsburgh

Phase 2 Completed
25 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT02956772 2017-02-23

Transcatheter Arterial Chemoembolization (TACE) in Combination With Arsenic Trioxide Versus TACE in the Treatment of Middle-advanced Primary Hepatocellular Carcinoma (HCC) Patients

Hunan Provincial People's Hospital

Phase 2 Unknown
190 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT00582400 2016-02-19

A Phase II Protocol of Arsenic Trioxide (Trisenox) in Subjects With Advanced Primary Carcinoma of the Liver

The University of Texas Medical Branch, Galveston

Phase 2 Terminated
9 enrolled 7 charts
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡